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Background: The World Health Organization recommends exclusive breastfeeding until 6 months followed by
introduction of iron-rich complementary foods (CFs). The aim of this study was to determine the impact
of different iron-rich CFs on infant gut inflammation and microbiota.
Methods: Eighty-seven exclusively breastfed infants were randomly assigned to receive one of the following
as their first CF: iron-fortified cereal (Cer), iron-fortified cereal with fruit (Cer + Fr), or meat (M). Urine and stool
samples were collected to assess reactive oxygen species (ROS) generation, gut microbiota and inflammation.
Results: Fecal iron differed across feeding groups (p < 0.001); levels were highest in the Cer group and lowest
in M group. A significant increase of fecal ROS formation (p < 0.002) after the introduction of CFs was observed, but did
not differ across feeding groups. Fecal calprotectin increased within all groups after the introduction of CFs (p = 0.004).
Gut microbiota richness increased after introduction of M or Cer + Fr. Regardless of feeding group, Coriobacteriaceae
were positively correlated with ROS and Staphylococcaceae were negatively correlated with calprotectin.
Conclusions: Choice of first CF may influence gut inflammation and microbiota, potentially due to variations in iron
absorption from different foods. Further research is warranted to fully characterize these associations and to establish
implications for infant health. This study was registered in the ClinicalTrial.gov registry (Identifier No. NCT01790542).
Trial registration: This study was registered in the ClinicalTrial.gov registry under the name “Assessment of
Complementary Feeding of Canadian Infants” (Identifier No. NCT01790542) February 6, 2013.
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By 6 months of age, breastfed infants become
dependent on complementary foods (CFs) as a source
of iron to prevent iron deficiency (ID), as a result of
declining iron stores present at birth and low levels
of iron in breast milk [1]. The World Health
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have devastating effects on neurodevelopment [2, 3]. In
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excessive iron exposure in the intestinal tract and initi-
ation of the inflammatory process by reactive oxygen
species (ROS) generation [7, 8]. With such a high
amount of iron in fortified cereals and low absorption
rates, concerns have been raised about the possibility of
the unabsorbed excess iron in these CFs causing ROS
generation and inflammation in the large intestine of
infants [9].
Cumulative evidence indicates that anti-oxidant rich
foods, such as fruits prevent ROS generation, inflam-
mation and disease initiation [10]. A study by Orozco
et al. conducted on adults who received a high iron
dosage of 120 mg/d has implicated iron in oxidative
stress and inflammation [11], which was ameliorated
with a concurrent administration of an antioxidant
supplement. Infants introduced to iron-fortified ce-
reals are receiving an equivalent dose of iron per kilo-
gram body weight to adults in the Orozco et al. study
and may be producing ROS, leaving them prone to
inflammation [12, 13].
The human gut harbors a complex microbial ecosys-
tem consisting of more than 1000 microbial species that
contribute to host metabolism, endocrine signaling and
immunity [14]. Dysbiosis of the infant gut microbiota
may have long-term health implications including in-
creased risk of allergic disease, obesity and other inflam-
matory and gastrointestinal disorders [15]. Animal
studies suggest that iron supplementation may alter
composition of the gut microbiota [16], but only two
human studies have addressed this potential association
in infants [17, 18].
To date, no studies have considered the safety of iron-
fortified cereal (traditional) and meat from the ROS gen-
eration and inflammatory perspective and few studies
have assessed the effect of iron fortification on the gut
microbiome of breastfed infants. Therefore, the aim ofFig. 1 Study designthis study was 1) to assess and determine the safety of
the traditional and the recently recommended first CFs
in regards to ROS generation and inflammation, 2) to
determine if the presence of antioxidant (fruit) in the
iron fortified cereal reduces the oxidative effect of
iron in the intestinal tract, 3) and to determine the
impact of different recommended CFs on infant gut
microbiota.
Methods
Eighty-seven full term healthy exclusively breastfed
(EBF) infants were randomly assigned to one of three
study foods: iron-fortified cereal (Cer), iron-fortified
cereal with fruit (Cer + Fr), or meat (M). The random
allocation sequence for the three feeding groups was
generated using computer generated random numbers.
This was done by the statistician of the Children’s
Hospital Research Institute of Manitoba, Winnipeg,
Manitoba using SAS/STAT software (SAS Institute Inc.,
Cary, NC, USA). Written informed consent was ob-
tained from all caregivers before participation. The care-
givers of the participating infants were blinded to the
allocation in this trial, however, not to the CF. A total of
90 infants were assessed for eligibility. Three infants
were excluded and the remaining 87 were enrolled in
the study between December 2012 and May 2014 (25 in
Cer group, 28 in Cer + Fr group and 34 in M group).
The foods were the first CFs introduced to the infants
and were consumed for a period of 2–4 weeks (Fig. 1).
The study consisted of two visits in which urine, stool,
dietary records and growth measurements were col-
lected. In addition, a questionnaire was completed at the
first visit to obtain socio-demographic characteristics
and infant feeding patterns. Nutrient intakes were
obtained using 3-day food records completed by care-
givers. Nutrient intakes, socio-demographics, feeding
patterns and infant growth were secondary outcomes
Table 1 Nutritional composition of study foods
Iron fortified rice




Per 28 g (7–8 tbs)
Meat Per
100 ml (1 jar)
Energy (Kcal) 120 120 140.9
Protein (g) 4.0 3.0 12.0
Carbohydrate (g) 21.0 21.0 0.3
Fibre (g) 0.0 0.0 0.3
Sugar (g) 3.0 4.0 0.0
Fat (g) 2.5 2.5 10.5
Cholesterol (mg) ND ND 29.4
Vitamin A (μg) 0.0 0.0 5.1
Vitamin B12 (μg) 0.35 0.17 1.4
Vitamin B6 (mg) ND ND 0.1
Thiamin (mg) 0.36 0.27 0.1
Riboflavin (mg) 0.38 0.38 0.2
Niacin (NE) 0.20 0.20 3.8
β Carotene (μg) ND ND 55.3
Vitamin C (mg) 0.00 0.00 0.0
Vitamin D (IU) ND ND 10.1
Vitamin E (IU) ND ND ND
Sodium (mg) 20.0 20.0 38.5
Potassium (mg) ND ND 190.5
Calcium (mg) 30.3 20.0 4.1
Iron (mg) 8.80 8.80 1.3
Zinc (mg) 0.09 0.07 ND
Copper (μg) 13.2 13.2 ND
Magnesium (μg) 11.2 15.0 ND
Phosphorus (mg) 41.2 41.2 92.2
Iodine (μg) 13.0 13.0 ND
Manganese (mg) 0.04 0.00 ND
Selenium (μg) ND ND 2.7
Nutritional composition was calculated using the nutritional analysis software
FoodFocus (Winnipeg, MB, Canada) and from food labels
NE niacin equivalent, ND no data provided, tbs table spoon
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was approved by the Bannatyne Campus Research Ethics
Board, University of Manitoba and the Winnipeg
Regional Health Authority Research Review Committee.
The study was registered in the ClinicalTrial.gov registry
(Identifier No. NCT01790542).
Inclusion criteria
Infants who fullfilled the following inclusion criteria
were considered eligible for participation: full term (>37
gestational weeks), birth weight of > 2500 g, absence of
congenital anomalies and medical conditions, EBF at 4 –
6 months of age. Infants were excluded if they had
started on complementary foods (other foods or liquids
than breast milk) or consumed formula.
Study foods
The three commercially available CFs (purchased) were
as follows: iron-fortified rice cereal (Milupa GmbH,
Danone, Friedrichsdorf, Germany), iron-fortified cereal
with raspberry, pureed beef (Heinz, Pittsburgh, PA,
USA). The nutritional compositions of the study foods
are illustrated in Table 1. Iron-fortified rice cereal was
selected because it was found to be the most common
first CF choice among Canadian infants. Iron fortified
rice cereal with fruit (raspberry) was selected because of
the following: it is another commonly consumed infant
cereal, contains a single fruit extract (raspberry powder)
ingredient, raspberry is a rich source of phenolic phyto-
chemicals and exhibits high antioxidant activities.
Pureed beef infant food was selected for the following
reasons: it contains single meat product (beef ), red meat
is a good source of heme iron, and it is recommended
by Health Canada.
Nutrient and breast milk intakes
The manufacturer presented the nutritional content of
the food in % daily value of the recommended intakes
(Dietary Reference Intakes, DRIs) rather than units,
therefore, we converted the % values to the amounts in
scientific units using the DRIs [19]. Dietary Iron and
nutrient intakes data from the food records were calcu-
lated using the nutritional analysis software FoodFocus
version 4 (Winnipeg, MB, Canada). Parents decided
when to begin feeding and reported this date. Breast
milk volume intake was estimated for each feeding dur-
ation recorded. For each minute, an estimated amount
of 12.5 ml was given and up to 125 ml for full feeding
lasting 10 min or longer [20, 21].
Growth
The growth of the infants (weight, height and head
circumference) was measured using standard techniques.Three measurements were taken for each variable and
the values were averaged.
Laboratory methods
Sample collection
Urine samples were collected by the infants’ caregivers
using the pediatric urine collector (Kendall pediatric urine
collector, Covidien, Mansfield, MA, USA) provided by the
study team along with instructions. Fecal samples were
collected from soiled diapers provided by the caregivers
and transferred to plastic collection tubes by the study
team. Urine and fecal samples were transported by the
study team using a cooler with ice packs, separated in
labeled 1.5 ml tubes and stored at -80 °C until analysis.
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F2-Isoprostanes are prostaglandin-like compounds pro-
duced as a result of free radical lipid peroxidation of ara-
chidonic acid [22]. Levels of urinary F2-isoprostanes
were determined by the liquid chromatography-mass
spectrometry (LC/MS/MS) assay method developed by
Davies et al [23]. Urinary creatinine concentrations were
determined using the Creatinine Parameter Assay kit
(R&D Systems Inc., Minneapolis, MN, USA) and follow-
ing the manufacture’s guidelines. We expressed F2-iso-
prostane levels relative to urinary creatinine levels to
normalize for excretion rate.Fecal iron
Stool samples (300–400 mg) were digested by acid mix
(6 M 37% HCL, 20% v/v trichloroacetic acid, Fisher
Scientific Inc., MA, USA) to extract the fecal iron [11].
After incubation at 65 °C for 20 h, the fecal iron content
was measured using the commercially available
spectrophotometrically-based assay Feren-B kit (Bioana-
lytic, Umrich, Freiburg, Germany).Fecal reactive oxygen species
High performance liquid chromatography (HPLC) was
used to quantify and separate the end products of
hydroxyl radical attack on salicylic acid, and resultant 3
products, particularly, 2,5 dihydroxybenzoic acid, 2,3
dihydroxy benzoic acid, and catechol using a method
validated by Orozco et al [11]. and adapted from
Owen et al [24]. Initially, a calibration curve was
constructed using the standards of salicylic acid, 2,5
dihydroxybenzoic acid, 2,3 dihydroxybenzoic acid, and
catechol. Fecal samples (100 mg) were incubated
(100 mM phosphate buffer, 500 mM ethylenediamine-
tetraacetic acid (EDTA), 50 μM FeCL3H2O, and
2 mM salicylic acid) (Sigma-Aldrich, St. Louis, MO,
USA) at 37 °C for 21 h. Following incubation, each
sample was filter-sterilized and 20 μl of each sample
was injected directly onto the HPLC column (ODS
Hypersil 200 x 2.1 Thermo Fisher Scientific Inc.). For
the chromatographic separation of compounds, the
mobile phase comprised of 2% acetic acid glacial in
water (solvent A) and methanol making up solvent B
utilizing the following gradient: 95% A/5% B for
2 min, 75% A/25% B for 8 min, 60% A/40% B for
10 min, 50% A/50% B for 10 min and 0% A/100% B
for 10 min. For the first 5.5 min, the UV/VIS de-
tector was adjusted at 278 nm and changed to
301 nm until completion of the run. The optimal
flow rate was 0.5 ml/min. Data handling and instru-
ment control were conducted by the software Chem-
Station (Agilent ChemStation, Agilent Technologies,
Santa Clara, CA, USA).Fecal calprotectin
Fecal calprotectin concentrations were determined using
the commercially available Calprotectin ELISA kit
(BUHLMANN Calprotectin ELISA, ALPCO, Salem, NH,
USA) and following the manufacture’s guidelines.
Fecal microbiota
Bacterial DNA was extracted from stool samples using
the ZR fecal DNA kit (Zymo Research, Irvine, CA,
USA), which included a bead-beating step for the mech-
anical lysis of the microbial cells. DNA was quantified
using a NanoDrop 2000 spectrophotometer (Thermo
Scientific). DNA samples were normalized to 20 ng/μl,
and quality checked by PCR amplification of the 16S
rRNA gene using universal primers 27 F (5’-GAAGA
GTTTGATCATGGCTCAG-3’) and 342R (5’-CTGCTG
CCTCCCGTAG-3’) as described previously [25]. Ampli-
cons were verified by agarose gel electrophoresis. The
V3-V4 region of the 16S rRNA gene was amplified using
modified F515/R806 primers [26] as described before
[27]. The reverse PCR primer was indexed with 12-base
Golay barcodes, allowing for multiplexing of samples.
For each sample, the PCR reaction was performed and
the V3-V4 library was generated and quantified as de-
scribed [25]. The 300 paired-end sequencing reaction
was performed on a MiSeq Ilumina platform at the Gut
Microbiome and Large Animal Biosecurity Laboratories.
Paired-end sequences were merged using the PANDA-
seq assembler and standard QIIME pipelines were used
to filter singletons [27, 28], remove chimeric reads and
assign sequences to operational taxonomic units (OTUs)
through alignment with the Greengenes reference data-
base (version 13_5) [29]. After cleaning and processing,
a total of 3.3 million reads were retained (median 30,500
per sample, range 14,500–45,900), representing 5,202
unique OTUs. For subsequent analyses, data were
rarefied to 14,500 sequences per sample.
Statistical analysis
Statistical analyses of iron, ROS and inflammatory bio-
marker data were performed using the statistical soft-
ware package IBM SPSS version 22.0 (IBM Corp.
Armonk, NY, USA). To compare feeding group means
at two different time points, repeated measures analysis
of variance (ANOVA) was used. For pair-wise compari-
sons, the post hoc Bonferroni test was used. P-values
<0.05 were considered statistically significant. Micro-
biome analyses were performed using QIIME version
1.9.0 (qiime.org) and SAS version 9.2 (SAS Institute Inc.,
Cary, NC, USA). The Chao1 estimator of species rich-
ness and the Shannon Diversity Index were calculated to
evaluate microbiota diversity within samples; these indi-
ces were normally distributed and comparisons were
made by ANOVA or two-sided t-test. Permutational
Table 2 Baseline comparisons of the three study group’s characteristics
Variable Cer Cer + Fr M All groups
(n = 22) (n = 28) (n = 32) (n = 82)
Males (%) 44.0 48.3 54.8 49.4
Birth weight (g) mean ± SD 3437 ± 475 3693 ± 494 3544 ± 519 3563 ± 503
Length at birth (cm) mean ± SD 52 ± 2.8 52.5 ± 2.6 51.7 ± 2.7 52 ± 2.7
HC at birth (cm) mean ± SD 34.1 ± 2.0 34 ± 1.9 35.5 ± 1.8 34.7 ± 1.9
Gestation (wk) mean ± SD 39.8 ± 1.3 39.8 ± 1.7 39.4 ± 1.0 39.7 ± 1.4
Parity (%)
1 32 27.6 35.5 31.8
2 36 41.4 51.6 43.5
≥ 3 32 30.8 12.9 24.8
Parity mean ± SD 2.0 ± 0.8 2.3 ± 1.5 1.8 ± 0.9 2.0 ± 1.1
Mean Maternal age (years) 31.1 ± 4.4 31.9 ± 4.1 34.5 ± 3.7* 32.6 ± 4.3
Mode of delivery (%)
Vaginal 83.3 92.3 83.3 86.3
Caesarian 12.5 3.8 16.7 11.3
Other 4.2 3.8 0.0 2.5
Antenatal-postnatal complication (%)
Yes 24 20.7 29 24.7
No 76 79.3 71 75.3
Fe supplementation during pregnancy (%) 20 31 25.8 25.9
Vitamin supplementation during pregnancy (%) 88 89.7 96.8 91.8
Vitamin supplementation during BF (%) 48* 62.1* 79.3* 63.9
Marital status (%)
Married 88 93.1 93.5 91.8
Single 4.0 6.9 0.0 3.5
Divorced 0.0 0.0 0.0 0.0
Common-law 8.0 0.0 6.5 4.7
Maternal pre-pregnancy weight (Kg) mean ± SD 67 ± 14.7 66.6 ± 12.1 69.8 ± 14.7 67.9 ± 13.8
Maternal height mean ± SD 165 ± 6.3 166.3 ± 6.9 166.5 ± 7.5 166 ± 6.9
Maternal pre-pregnancy BMI mean ± SD 24.6 ± 4.4 24.1 ± 3.9 25.3 ± 5.3 24.7 ± 4.6
Duration of previous BF (months) mean ± SD 14.9 ± 8.9 12.3 ± 7.5 13.4 ± 6.2 13.5 ± 7.4
Maternal education (%)
Primary & secondary 16 10.7 9.7 11.9
Post secondary 84 89.3 90.3 88.1
Pre-delivery working mothers (%) 76 85.7 96.8 86.9
Paternal weight (Kg) mean ± SD 88.4 ± 14.9 92 ± 18.8 87.9 ± 11.7 89.5 ± 15.2
Paternal height mean ± SD 179.5 ± 8.0 180 ± 7.1 180 ± 7.9 180 ± 7.6
Paternal BMI mean ± SD 25.1 ± 8.7 28.3 ± 5.3 27.0 ± 4.2 26.9 ± 6.1
Paternal education (%)
Primary & secondary 16.0 3.8 3.2 7.3
Post secondary 84.0 96.2 96.8 92.7
No. of household occupants mean ± SD 3.9 ± 0.8 4.3 ± 1.5 3.9 ± 1.0 4.0 ± 1.2
No. of household children mean ± SD 1.8 ± 0.7 2.4 ± 1.5 1.9 ± 0.9 2.0 ± 1.1
Maternal smoking (%) 4.0 0.0 3.2 2.4
Infant Vitamin D supplementation (%) 96.0 100.0 90.3 95.3
BF Breastfeeding, BM breast milk, *: p < 0.05
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dinates analysis (PCoA) of unweighted UniFrac distance
matrices were used to assess between-sample differences
in microbiota diversity and community structures [30].
The OTUs relative abundances were compared between
feeding groups by non-parametric Kruskal-Wallis or
Wilcoxon rank sum test, with false discovery rate cor-
rection for multiple comparisons. Spearman correlations
were used to explore associations of microbiota parame-
ters with fecal iron, calprotectin and ROS. Effects were
considered significant at p < 0.05. Trends were discussed
at p < 0.1.
Results
A total of 82 infants completed the study; 5 withdrew
(did not receive allocated intervention) due to the fol-
lowing reasons: mothers refused to comply with the
assigned study food (n = 3), moved to a different
province (n = 1), or failed to respond to study com-
munications (n = 1). The baseline characteristics of
study infants are shown in Table 2. There were no
statistical significant differences between the groups
for these characteristics except for higher maternal
age and the use of vitamin supplementation during
breastfeeding in mothers of the M group.
The primary outcome was fecal ROS generation.
According to Orozco et al., the mean of ROS was found
to be 10% less in adults who received antioxidant supple-
ments [11]. Therefore, minimum sample size required for
each group was 25 (N = 75) which was set at a significance
level (α) 0.05 with power (β = 5%) of 95%. Due to insuffi-
cient sample volumes, the number of infant samples avail-
able to be analyzed for each outcome varied. The sample
numbers analyzed were as follows: 25 urine samples for
F2-Isoprastanes analysis, 77 stool samples for fecal iron
analysis, 66 stool samples for fecal ROS analysis, 43 stool
samples for fecal calprotectin, and 56 stool samples for
microbiome. Table 3 summarizes the biomarker measures
of infants in the study groups.Table 3 Summary of biomarker measures of infants in the three stu
Biomarker
(mean ± SE)
Cer Cer + Fr
Before CFs After CFs Before CFs After
Urinary F2-Isoprostane N = 7 N = 7 N = 8 N = 8
(ng/mg) (n = 25) 0.45 ± 0.81 0.52 ± 0.78 0.35 ± 0.47 0.41 ±
Fecal iron N = 22 N = 22 N = 26 N = 26
(Fe g/feces) (n = 77) 3.9 ± 0.37 5.6 ± 0.38 3.9 ± 0.32 4.7 ±
Fecal ROS N = 16 N = 16 N = 21 N = 21
(mmol/l) (n = 66) 0.024 ± 0.007 0.037 ± 0.006 0.014 ± 0.003 0.031
Fecal calprotectin N = 14 N = 14 N = 19 N = 19
(mg/g feces) (n = 43) 111.0 ± 12 122.3 ± 13 93.73 ± 12 154.5
*: P < 0.05 by repeated measures ANOVADietary iron intake
The dietary iron intakes of the infants (Cer n = 22, Cer +
Fr n = 28, M n = 32) are reported in Table 4. There was
an increase in iron intake after the introduction of the
CFs in all groups (p < 0.05).
Breast milk and nutrient intake
After the introduction of CF, the amount of breast milk
intake decreased significantly within groups (over time).
However, there was no significant difference between
the groups in the intake of breast milk. There was a sig-
nificant difference in energy intake within groups (over
time) except for the M group (Additional file 1: Table
S1, Additional file 2: Table S2 and Additional file 3:
Table S3). Carbohydrate intake was significantly lower in
the M group (p = 0.04). There were no significant differ-
ences in most of vitamins and minerals intake within the
groups (over time) or between the groups.
Growth
There were no significant differences in growth rates
between male infants and female infants. Over all, no
significant differences were seen in growth rates between
the feeding groups (data not shown).
Urinary F2-isoprostanes
The effect of the three foods on the excretion of the
urinary F2-Isoprostanes (Cer n = 7, Cer + Fr n = 8, M
n = 10) was not significant, although our sample size
was small for this analysis (Fig. 2a).
Fecal iron
Seventy-seven fecal samples (Cer n = 22, Cer + Fr n = 26,
M n = 29) were analyzed for fecal iron (Fig. 2b). After
the introduction of the CFs, there was an increase in the
amount of fecal iron within groups (over time) (p <
0.001). There was also a feeding group effect (p < 0.001)
with lower fecal iron levels in the M group (p < 0.001 vs.




CFs Before CFs After CFs
N = 10 N = 10 0.3 0.5 (Cer vs M)
0.08 0.48 ± 0.14 0.68 ± 0.12 0.5 (Cer vs Cer + Fr)
N = 29 N = 29 <0.001* <0.001* (Cer vs M)
0.34 2.9 ± 0.25 3.7 ± 0.25 0.014* (Cer + Fr vs M)
N = 29 N = 29 0.002* 0.6 (Cer vs M)
± 0.005 0.023 ± 0.004 0.028 ± 0.003 0.3 (Cer vs Cer + Fr)
N = 10 N = 10 0.004* 0.07 (Cer vs Cer + Fr)
± 23 108.1 ± 11 131.9 ± 18 0.9 (Cer vs M)
Table 4 Dietary iron intake before and after introduction of complementary foods (CFs) in the three study groups
Before CFs After CFs
Feeding group Cer Cer + Fr M Cer Cer + Fr M
(n = 22) (n = 28) (n = 32) (n = 22) (n = 28) (n = 32)
Iron (mg) (mean ± SE) 0.28 ± 0.01 0.28 ± 0.01 0.29 ± 0.01 16.3 ± 2.5* 21.5 ± 3.4* 0.86 ± 0.08*,**
Dietary Iron intake data from the 3-day food records was calculated using the nutritional analysis software FoodFocus© (Winnipeg, MB, Canada)
* values superscript letters are significantly different intake within groups (over time) (p < 0.05) by repeated measures ANOVA
** values superscript letters are significantly different between the groups (p < 0.05) by repeated measures ANOVA
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In total, 66 fecal samples (Cer n = 16, Cer + Fr n = 21, M
n = 29) were analyzed for formation of hydroxylated
products, indicating the production of ROS (Fig. 2c).
After the introduction of the CFs, there was an increase
in ROS generation within groups (over time) (p < 0.05).
No differences were found between groups.
Fecal calprotectin
A total of 43 fecal samples (Cer n = 14, Cer + Fr n = 19,
M n = 10) were analyzed to determine calprotectin con-
centration. There was a significant effect of time (p =
0.004) for fecal calprotectin level in all feeding groups
(Fig. 2d). There was no significant difference observed
between the CF groups. However, in post hoc analysis of
the groups, fecal calprotectin of the Cer + Fr tended to
be higher when compared to the Cer group (p 0.07).Fig. 2 Comparisons between the feeding groups and over time for fecal iron,
complementary foods. Error bars indicate +/- 2 SE; comparisons by repeated m
(n= 25). No significant differences between groups or over time. b Fecal iron in
time. **Significant difference between the groups. c Total hydroxylated produc
time. d Fecal calprotectin concentration in the three study groups (n= 43). *SigFecal microbiota
Fecal microbiota was characterized in 56 infants (Cer,
n = 18; Cer + Fr, n = 19; M, n = 19) before and after
introduction of CFs. Gut microbiota richness in-
creased following introduction of Cer + Fr or M,
whereas no change was observed in the Cer group
(Fig. 3). Across feeding groups, the relative abun-
dances of dominant bacterial phyla and families were
similar (Fig. 4a and b) and there were no clear differ-
ences in microbiota community structures (Fig. 4d,
PERMANOVA p = 0.22). The median relative abun-
dance of Bifidobacteriacea declined from 51% to 37%
after introduction of iron-fortified Cereal, but
remained relatively unchanged after introduction of
meat (from 41% to 42%). Bacteroidetes increased with
the introduction of CF across all feeding groups,
reaching the highest levels (14%) in the Cer group.ROS, and inflammatory biomarkers at before and after introduction of
easures ANOVA; (a) Average creatinine corrected F2-isoprostanes in urine
the three study groups (n= 77).*Significant difference (p< 0.05) over
ts in the three study groups (n= 66). *Significant difference (p < 0.05) over
nificant difference (p< 0.05) over time
Fig. 3 Change in microbiota richness and diversity after introduction of complementary foods. a Microbiota richness and diversity by feeding
group. b Chao1 richness estimator. c Shannon diversity index. Bars indicate means with 95% confidence intervals. Between-group comparison
by ANOVA. *Significant change from baseline (p < 0.05)
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group (Fig. 4c; median relative abundance 10.35% vs.
5.0% in the Cer group; p < 0.05); however, none of
these differences were significant after correction for
multiple comparisons. Some fecal microbiota parame-
ters correlated with iron, ROS and calprotectin mea-
surements (Fig. 5). Before introduction of CFs,
microbiota richness was positively correlated with
ROS (Spearman r = 0.51, p < 0.001), but there was no
correlation after introduction of CFs (r = 0.15, p =
0.29) (Fig. 5a). Both before and after introduction of
CFs, the relative abundance of Coriobacteriaceae was
positively correlated with ROS (Fig. 5c), and the rela-
tive abundance of Staphylococcaceae was negatively
correlated with calprotectin (all p < 0.005) (Fig. 5d).
Discussion
This is the first RCT to investigate the effect of different
first CFs on oxidative stress, inflammation and gut
microbiota in healthy EBF infants. Several important
findings emerge from the current study. Residual fecal
iron was lower in the M group compared to the cereal
groups. The urinary oxidative stress marker, F2-Isopros-
tane, did not change with introduction of CFs and was
similar across the CF groups; however, the fecal oxida-
tive stress marker of ROS production increasedsignificantly within groups over time. Fecal calprotectin
concentration increased significantly after the introduc-
tion of the CFs within groups. Finally, some gut micro-
biota differences were identified across feeding groups,
and a number of associations with ROS and calprotectin
were observed.
Oxidative stress and inflammation
To our knowledge, no previous studies had evaluated
the effect of different iron-fortified CF regimens on the
oxidative stress status of EBF infants. A previous study
conducted on three healthy adults who received daily
120 mg of oral iron for 7 days, showed that two of the
subjects had a two-fold increase in urinary F2-Isopros-
tanes from the baseline [8]. Among the few studies that
report normal F2-Isoprostanes levels in healthy children
[22], there was an inverse association between age and
the concentration of urinary F2-Isoprostanes (β coeffi-
cient: -0.14, p = 0.0001) [22]. In the current study the
levels of urinary F2-Isoprostanes increased after the
addition of the CFs, but these values remained in the
normal range of urinary F2-Isoprostanes [22].
Our results are in keeping with those reported in a
previous study conducted by Orozco et al. on seventeen
healthy men who received daily 120 mg of iron for 2 -
cycles of 7 days supplementation. From that study, it
Fig. 4 Gut microbiota composition before and after introduction of complementary foods (CFs). a Median relative abundance of dominant phyla
and families before and after introduction of CFs, by feeding group. Dominant taxa are those with >0% median relative abundance. *Significant
difference (p < 0.05) by Wilcoxon ranked sum test, compared to Cer group. b Mean relative abundance of dominant microbiota phyla by feeding
group, before and after introduction of CFs. c Relative abundance of Enterobacteriaceae after introduction of CFs. Bars indicate medians. *Significant
difference (p < 0.05) by Wilcoxon rank-sum test. d Principal components analysis of microbiota community structures (unweighted UniFrac distance)
after introduction of CFs; statistical comparison by PERMANOVA with 500 permutations
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was a significant increase in fecal ROS production by
36% (p = 0.026) [11]. Similarly, in the current study,
after the provision of iron-rich foods, ROS generation
increased significantly by 55% (p = 0.003). Differences
between these studies may be explained by the differ-
ences between adult and infant intestinal iron absorp-
tion. Previous studies have suggested that the dietary
regulator of iron absorption between 6 and 9 months
of age is immature and remains under development
[31]. An additional difference between the adult study
by Orozco et al and the current study is the form of
the iron administered, which was a single supplement
for the adults vs a poorly absorbed elemental iron
fortificant in the infant CF. Another possible cause is
the individual variation in the iron stores, which
might have influenced the absorption rate thus affect-
ing the amount of intestinal residual iron and ROS
production [32]. In the current study, differences be-
tween groups in ROS generation were not significant
despite differences in energy intake between the two
cereal groups versus the M group. This finding sug-
gest that ROS generation in response to feeding is an
expected process in the under developed intestinal
tract of the growing infants regardless of the type and
amount of food. Another important factor that isnoteworthy to mention is the phytate content of the
iron-fortified cereals that might have interfered with
iron absorption [33].
Our findings did not support our hypothesis that fruit
added to iron-fortified cereal would ameliorate ROS
generation in the intestinal tract. Rather, our results sug-
gest that the average daily iron intake from Cer + Fr of
21.5 ± 3.4 mg (67.5 g of cereal/d) was enough to increase
the production of ROS regardless of the fruit content.
The low content of raspberry powder (1.8%) in the Cer
+ Fr was insufficient to eliminate the oxidative effects. In
addition, it is possible that the raspberry powder may
have lower antioxidant activity compared to fresh rasp-
berry fruit, due to variations in drying techniques and
processing.
In the current study differences in the baseline of both
residual fecal iron and ROS generation were observed
before the introduction of solids. Although all of the
included infants were EBF, the variation in the use of
multivitamin supplements by the mothers, genetic
factors, the possibility of formula consumption, and ana-
lytical errors might have contributed to these observa-
tions [34, 35].
There are no existing studies that have measured
calprotectin concentration in response to iron fortifica-
tion. Our study showed a significant feeding effect with
Fig. 5 Correlations of fecal microbiota, iron, ROS and calprotectin, before and after introduction of complementary foods (CFs). a Spearman
correlation matrix of dominant taxa (phyla and families with median relative abundance >0%) with fecal iron, ROS and calprotectin. b Correlation
of microbiota richness and ROS, before CF: r = 0.51, p = 0.0001; after CF: r = 0.15, p = 0.29. c Correlation of Coriobacteriaceae and ROS, before
CF: r = 0.39, p = 0.005; after CF: r = 0.46, p = 0.001. d Correlation of Staphylococcaceae and calprotectin, before CF: r = -0.54, p = 0.001; after
CF: r = -0.59, p = 0.0003
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protectin levels in the Cer + Fr group. Fecal calprotectin
concentration has been used to evaluate the degree of
inflammation in various systemic and gastrointestinal
conditions [36, 37]. Although the current study found
that fecal calprotectin concentrations have increased
after the introduction of CFs, these elevations remained
within the suggested normal values of calprotectin for
this age group [38–40]. In a previous study conducted
on 74 (39 EBF and 35 formula-fed) term Italian in-
fants, it was reported that the median fecal calprotec-
tin was higher in EBF infants than in formula fed
infant (p < 0.001) [41]. It was concluded that there
was a feeding effect on calprotecin concentration,
which might be due to the effect of human milk
bioactive molecules, which clearly contribute to the
development of the gastrointestinal system [41].
Another study had also indicated that calprotectin is
higher in EBF infants than in mixed fed infants [42].
Fecal microbiota
In agreement with previous studies [18, 43], we found
that gut microbiota richness increased after the intro-
duction of CFs. In an observational study, Thompson
et al. reported increased richness among infants con-
suming solid foods, but they did not investigatedifferences by type of CF. In our study, richness in-
creased after the introduction of meat but no change
was observed with iron-fortified cereal. Similar results
were reported in a recent RCT of American infants by
Krebs et al [18]. In another RCT by Jaeggi et al. [17],
iron supplementation was found to adversely affect the
gut microbiota of Kenyan infants by increasing the
abundance of pathogenic bacteria, including members of
the Enterobacteriaceae family. In contrast, we found that
Enterobacteriaceae were more abundant in the meat
group compared to the cereal groups; however, we did
not perform targeted quantitative analyses to identify
pathogenic strains. In addition, the difference in the set-
tings between the Kenyan study and ours, such as the
poor sanitation and the prevalence of intestinal infec-
tions, might have contributed to this variation between
our results compared to the Kenyan study. Ours is the
first study to evaluate associations between infant gut
microbiota and fecal ROS, finding a positive correlation
with Coriobacteriaceae. This family from the Actinobac-
teria phylum is typically elevated in formula versus
breast-fed infants and has been linked to host lipid
metabolism [44]. Taken together, our results add to
existing evidence that iron fortification influences the
infant gut microbiota, with potential implications for the
developing immune system.
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A major strength in the current study is the use of a con-
trolled randomized design, which is considered the gold
standard for nutritional intervention. The precise CF given
to the caregivers allowed more isolation of the effect of
iron from the CFs on the endpoint measures and reduced
possible confounding influences from other foods if given.
However, some mothers reported feeding their infants
other foods or formula (10%). Other limitations of the
current study were the variability in the time of the intro-
duction of CFs between the infants (at parents’ discretion)
and the short feeding duration. Another limitation was
the incomplete collections for urine and fecal samples for
all infants, which resulted in variations in the total number
of samples analyzed for each outcome. These limitations
could have impaired our ability to detect differences be-
tween the groups. Although the present study was suffi-
cient in sample size to detect differences in fecal ROS
generation, some comparisons of other analytes were
underpowered to observe differences between the groups.
Conclusion
The current RCT highlights clinically important findings
to inform infant feeding guideline updates regarding the
optimal first CFs. The results of this study do not sup-
port the notion that iron fortification causes untoward
effects of ROS generation in the intestinal tract of
breastfed infants. The current study provides new evi-
dence for the effect of iron-fortified CFs on the develop-
ing infant gut microbiota. Further long-term study is
required to determine the association between ROS gen-
eration in the intestinal tract, inflammatory markers and
infant gut microbiota with subsequent health outcomes.
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Additional file 1: Table S1. Energy and macronutrient intake before
and after introduction of CFs in the three study groups. Description of
data: this table presents the total energy, carbohydrates, protein and fat
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Additional file 3: Table S3. Selective minerals intake before and after
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